- A first-in-class consumer product, backed by clinical data: In a randomised trial of more than 1,000 real-world episodes, Klario cut the risk of repeat hypos by 27% and reduced “hypo hangover” effects, compared with standard glucose-only products.
- A four-person team with an outsized track record: Flow Health Science has been named an ADA Innovation Challenge finalist (top 5 globally), won Best Health Innovation at the World Food Innovation Awards, and was named Innovative StartUp of the Year (London) at the UK StartUp Awards.
- The next chapter: Selected from a record 1,590 applications, Georgia joins the Awards' 10th anniversary cohort — recognition that comes as she leads Klario from clinical validation toward wider commercial rollout.
London, UK – Flow Health Science is the London-based advanced nutrition company behind Klario®, a first-in-class hypoglycaemia recovery drink for people living with diabetes. Klario tackles the “hypo hangover” — the fatigue and brain fog that can persist for hours after a low blood sugar episode — by combining 15g of fast-acting carbohydrates with additional energy sources in a convenient, ready-to-drink format. In a randomised clinical trial analysing more than 1,000 hypoglycaemic episodes, Klario was associated with a 27% reduction in recurrent hypos, with participants reporting faster relief of hypo symptoms, reduced hypo hangover effects, and feeling more in control when managing episodes, compared with standard glucose-only treatment.
The four-person team has spent the past year building on this science with a body of clinical and industry validation: publication in the leading peer-reviewed journal Diabetes, Obesity and Metabolism, an ADA Innovation Challenge Finalist place (top 5 globally), Best Health Innovation at the World Food Innovation Awards, and Innovative StartUp of the Year at the UK StartUp Awards (London). Now, Co-founder and CEO Georgia Myers adds a further accolade — named among Innovate UK's 100 Women Entrepreneurs in the Women in Innovation Awards' 10th anniversary cohort, selected from a record 1,590 applications.
“Building a clinically-proven product in an underserved space hasn't been easy, and this recognition is a real vote of confidence — not just in me, but in Klario's science and the team behind it. We're just getting started: this support couldn't come at a better moment as we gear up for our next phase of growth.” — Georgia Myers, Co-founder and CEO, Flow Health Science
About Innovate UK
Innovate UK is the UK's innovation agency. It backs deep tech businesses in the UK's priority sectors for national benefit, supporting their journey from startup to scaling business to industry leader. It provides the funding, expert support and connections to help breakthrough ideas reach their potential, improve lives and drive economic growth. Innovate UK is part of UK Research and Innovation.
About the Innovate UK Women in Innovation Awards
The Innovate UK Women in Innovation Awards launched in 2016, to address the biggest challenges facing women innovators, including access to funding and finance, the lack of visible role models, and difficulty accessing key networks. Over the past decade, the Awards have supported hundreds of women entrepreneurs to grow and scale innovative businesses, while inspiring more women and girls to see innovation and entrepreneurship as a viable career path.
About the Product
Klario®: A Novel Approach to Hypoglycaemia Management
Hypoglycemia represents a critical therapeutic challenge in diabetes management: people with T1D may experience 100–200 treatment-related episodes annually. Current recommended therapeutic interventions using glucose-only treatments frequently result in suboptimal outcomes, including rapid glucose fluctuations, persistent neuroglycopenic symptoms, and fear-driven non-adherence to medication. Klario, a novel multi-substrate energy formulation combining glucose with BHB, was designed to achieve more complete recovery from hypoglycemia. In line with medical guidelines, Klario delivers 15 grams of fast-acting carbs to raise blood glucose quickly, while also raising BHB levels acutely. This combination formula improves glycemic control in the immediate post-treatment period and provides rapid, sustained neuroglycopenic recovery. For more information about Klario, please visit myklario.com.
About Flow Health Science
Flow Health Science is dedicated to transforming health outcomes through trusted, clinically-proven functional foods. Grounded in advanced metabolic science, our research and pipeline targets diabetes management, fatigue, hormone imbalances, and broader metabolic dysfunction.
Media Contact: Tara Lumley, Chief Strategy & Business Officer — press@flowhealthscience.com
Source: Flow Health Science